No medical body recommends a specific dose of testosterone for women who want to build muscle, and the reason is straightforward: at the doses considered safe for women, testosterone has not been shown to significantly increase muscle mass or strength. The 2019 Global Consensus Position Statement on testosterone therapy for women, endorsed by multiple international endocrine and menopause societies, concluded that physiologic doses produce no statistically significant effect on lean body mass, total body fat, or muscle strength. Higher doses can change the picture, but they push testosterone levels beyond the normal female range and into territory where virilization and cardiovascular risks emerge. The gap between “enough to work” and “safe for long-term use” is the core problem, and it has no clean resolution in the current evidence.
What the Global Consensus Says About Muscle
The most authoritative clinical guidance on testosterone for women comes from a 2019 global consensus statement published in the Journal of Clinical Endocrinology & Metabolism, developed by representatives from multiple major medical societies. Its conclusion on muscle is blunt: at physiologic doses, meaning doses that bring a woman’s testosterone up to the levels of a healthy premenopausal woman, there is no demonstrated benefit for lean mass, fat mass, or strength. The evidence behind this conclusion was graded at the highest level of certainty.1The Journal of Clinical Endocrinology & Metabolism. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
This matters because physiologic replacement is the only type of testosterone therapy that any medical organization has been willing to endorse for women, and even then only for a narrow indication: low sexual desire causing distress (hypoactive sexual desire disorder). The same consensus statement explicitly recommends against any testosterone preparation that results in supraphysiologic concentrations, singling out pellets and injections as delivery methods that tend to overshoot the target range.2PubMed Central. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
The Endocrine Society’s earlier clinical practice guideline struck a similar note, recommending against generalized testosterone use in women because the indications are inadequate and long-term safety data are lacking.3PubMed. Androgen therapy in women: an Endocrine Society Clinical Practice guideline
Why Physiologic Doses Do Not Move the Needle
The disconnect between testosterone’s well-known muscle-building reputation and its lack of effect at physiologic female doses has a few layers. The most basic one is the sheer scale difference between male and female testosterone levels. A healthy premenopausal woman typically has total testosterone somewhere around 15 to 70 ng/dL. A healthy man is usually between 300 and 1,000 ng/dL. Bringing a postmenopausal woman from very low levels back up to the premenopausal range represents a small absolute change in hormone exposure, and muscle tissue may simply not respond to it the way people expect.
There is also the question of which testosterone matters. A preprint from 2024 found that in premenopausal women, total testosterone was not associated with muscle mass, muscle strength, or how much muscle women gained from resistance training. What did correlate was bioavailable testosterone, the fraction not bound up by carrier proteins, along with how much androgen receptor was actively localized to the cell nucleus. Women can have similar total testosterone levels but very different amounts of the hormone that is actually available to act on muscle tissue. This helps explain why simply raising total testosterone to a “normal” number does not guarantee a muscle response.
At the cellular level, testosterone clearly can stimulate muscle protein production. A study in postmenopausal women found that testosterone treatment increased the rate of muscle protein synthesis by roughly 50%, a significant jump.4Journal of Clinical Endocrinology and Metabolism. Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women But a faster rate of protein synthesis in a lab measurement does not automatically translate into visible gains in muscle size or strength on the scale of months, especially if the dose stays within the physiologic range. A separate trial confirmed this disconnect directly: six months of standard hormone replacement therapy did not change muscle strength in postmenopausal women.5PubMed. Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women
Higher Doses That Actually Build Muscle
When researchers have pushed testosterone doses above the physiologic range, muscle effects start appearing. A randomized dose-response trial in hysterectomized women tested several weekly testosterone doses against placebo. At the 25-milligram dose, which was the highest tested and produced free testosterone concentrations well above the premenopausal reference range, women showed significant increases in lean body mass, chest-press power, and loaded stair-climb power compared to placebo. Women in the lower-dose groups did not see these benefits.6PubMed Central. Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial – Section: RESULTS
A separate proof-of-concept study in hysterectomized women with low testosterone found that testosterone administration increased the cross-sectional area of several trunk muscles. Paraspinal, psoas, and abdominal wall muscles all grew significantly compared to placebo, and the increases in psoas muscle area correlated with changes in free testosterone.7PubMed Central. The Effects of Testosterone Administration on Muscle Areas of the Trunk and Pelvic Floor in Hysterectomized Women with Low Testosterone Levels: Proof-of-Concept Study – Section: Results
The clearest demonstration of what sustained high-dose testosterone does in female bodies comes from research on transgender men receiving gender-affirming hormone therapy, where the goal is to bring testosterone into the adult male range. Longitudinal studies using body-composition scans have consistently shown about a 10% increase in lean mass over the first 12 months, accompanied by a roughly 10% decrease in fat mass. Muscle mass and strength in trans men on hormone therapy end up higher than in cisgender women but still lower than in cisgender men.8PubMed Central. The Impact of Gender-Affirming Hormone Therapy on Physical Performance – Section: Muscle Mass and Strength Changes With Gender-Affirming Hormone Therapy
These results paint a consistent picture: testosterone can build muscle in female bodies, but the threshold for meaningful gains sits above the physiologic range. And that is exactly the territory where risks escalate.
What Goes Wrong at Supraphysiologic Levels
The most visible risk of high testosterone in women is virilization: unwanted body hair, acne, deepening of the voice, and clitoral enlargement. Some of these changes, particularly voice deepening and clitoral growth, can be irreversible. Clinical endocrinology guidelines flag total testosterone above roughly 145 ng/dL (5 nmol/L) in women as a level where virilizing features become a concern, and where clinicians should even consider whether an androgen-producing tumor might be the cause.9PubMed Central. Dual case insights shaping a new protocol for post-menopausal hirsutism
Cardiovascular effects are less dramatic in the short term but potentially more consequential. A review of studies on testosterone therapy in postmenopausal women found mixed results: some trials showed improvements in functional capacity, inflammatory markers, and lean mass, while others reported drops in HDL cholesterol (the “good” kind), increases in visceral fat, greater insulin resistance, and higher cardiovascular disease risk.10PubMed Central. The Impact of Testosterone Therapy on Cardiovascular Risk Among Postmenopausal Women – Section: Results The fact that both positive and negative cardiovascular markers can move simultaneously makes long-term risk hard to predict for any individual woman.
Data from transgender men on full masculinizing doses offer a window into what more aggressive testosterone exposure does to lipids over time. Within the first several months of hormone therapy, HDL cholesterol dropped by about 16%, and triglyceride levels rose by 26 to 37%.11PubMed. Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy – Section: RESULTS These are meaningful shifts in cardiovascular risk markers, and they illustrate why endocrine societies are reluctant to endorse supraphysiologic testosterone in women whose primary goal is strength or body composition.
The Estrogen Complication
For postmenopausal women or those on oral estrogen therapy, there is an additional wrinkle. Oral estrogen increases the liver’s production of sex hormone-binding globulin (SHBG), a protein that latches onto testosterone and makes it unavailable to tissues. A study comparing postmenopausal estrogen users with nonusers found that although total testosterone levels were similar between the two groups, free testosterone was roughly halved in the estrogen users. Free testosterone, in turn, correlated significantly with total lean mass and leg lean mass. The implication: oral estrogen therapy may actually accelerate lean mass loss by reducing the testosterone that is biologically available to muscle.12PubMed. Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women
This creates a frustrating dynamic for postmenopausal women who take estrogen for bone health, hot flashes, or other menopausal symptoms. The estrogen they rely on for those benefits may simultaneously undermine the small amount of testosterone their bodies still produce. Transdermal estrogen (patches or gels) has a smaller effect on SHBG than oral estrogen, so some clinicians prefer that route when preserving free testosterone is a concern, but the overall impact on muscle in this context has not been well studied.
DHEA as an Indirect Route
DHEA (dehydroepiandrosterone) is a naturally produced hormone that the body can convert into both testosterone and estrogen. Because it is sold as an over-the-counter supplement in many countries, some women consider it as a gentler alternative to direct testosterone use. A randomized, placebo-controlled trial tested ten months of DHEA replacement in older adults, with the last four months combined with weight training. DHEA alone for six months did not significantly increase strength or thigh muscle volume. But when combined with resistance training, DHEA enhanced the gains in muscle strength and muscle volume beyond what exercise alone produced.13American Journal of Physiology-Endocrinology and Metabolism. DHEA enhances effects of weight training on muscle mass and strength in elderly women and men
The study included both men and women, and the finding is worth noting for women specifically because DHEA raises androgen levels more modestly than direct testosterone. The effect was not dramatic: DHEA did not turn elderly participants into powerlifters, and the supplement had no measurable benefit without the exercise component. But the fact that it amplified training responses suggests it may offer a small, less risky edge for women who are already lifting weights consistently. DHEA is not without its own side effects, including acne and mild hirsutism at higher doses, and it is banned by most sports governing bodies.
What Happens Beyond the Muscles
Testosterone does not only act on muscle tissue, and women considering it for any reason should be aware of its wider effects. A study in young women found that a single dose of testosterone significantly impaired cognitive empathy, the ability to read other people’s emotional states from facial cues.14PubMed Central. Testosterone administration impairs cognitive empathy in women depending on second-to-fourth digit ratio The magnitude of this effect varied considerably between individuals and was linked to a marker of prenatal testosterone exposure, suggesting that the hormone’s psychological effects are partly shaped long before any adult dose enters the picture.
On the other hand, a dose-response trial in hysterectomized women with low testosterone found no significant changes in spatial ability, verbal fluency, verbal memory, or executive function across any of the testosterone doses tested over 24 weeks. Multiple regression analysis showed no meaningful relationship between testosterone levels and cognitive performance.15PubMed Central. Effects of testosterone administration on cognitive function in hysterectomized women with low testosterone levels: a dose-response randomized trial The picture that emerges is that testosterone is unlikely to make women noticeably sharper or duller in standard cognitive tasks, though its effects on social cognition and emotional processing are less settled.
Why There Is No Approved Product
As of 2025, no testosterone product is approved by the FDA specifically for use in women, for any indication. Every prescription a woman receives for testosterone is technically off-label, meaning a doctor is prescribing a product approved for men (or a compounded formulation made by a specialty pharmacy) and adjusting the dose downward. The global consensus statement flagged this gap as a serious problem: compounded “bioidentical” testosterone preparations lack standardized quality control, and their efficacy and safety are less certain than those of approved pharmaceutical products.2PubMed Central. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
This regulatory void means that women who do use testosterone are navigating a landscape with no standardized dosing, no long-term safety trials designed for female physiology, and no FDA-reviewed labeling telling them what to expect. Clinicians who prescribe testosterone for women typically aim for a total testosterone level in the mid-to-upper premenopausal range, often around 30 to 50 ng/dL, using transdermal gels or creams at a fraction of the male dose. But as the evidence reviewed here shows, that target is unlikely to produce the muscle gains many women are hoping for. Reaching levels that reliably build muscle means crossing into supraphysiologic territory, where no guideline is willing to follow.
Resistance Training Without Testosterone
Given how narrow the therapeutic window is, it is worth reframing the question entirely. Women build muscle through resistance training at every age, with or without supplemental testosterone. The rate of gain is slower than in men, but muscle growth in response to progressive overload is a well-documented physiological response in women. Factors like training volume, protein intake, sleep quality, and consistency account for a far larger share of the variation in muscle outcomes among women than circulating testosterone levels do. The preprint mentioned earlier found that total testosterone was essentially irrelevant to how much muscle premenopausal women gained from resistance training, which fits with the broader observation that many women with perfectly average hormone levels build substantial muscle when training and nutrition are dialed in.
For postmenopausal women, who face accelerating muscle and bone loss, the conversation shifts somewhat. The combination of resistance exercise with hormonal support (whether estrogen, DHEA, or low-dose testosterone) is an area of active research. But even in this group, the single most reliable intervention for preserving and building muscle is progressive resistance training itself. Testosterone may eventually find a validated role as an adjunct in specific clinical situations, such as sarcopenia in older women, but the current evidence does not support using it as a primary muscle-building strategy. The honest answer to “how much testosterone should a woman take to build muscle” is that the dose that works is not the dose anyone recommends, and the dose that is recommended does not reliably work for that purpose.